Literature DB >> 26782362

Correlation Between the Expression of MicroRNA-301a-3p and the Proportion of Th17 Cells in Patients with Rheumatoid Arthritis.

Xinyi Tang1,2, Kai Yin3, Hongsheng Zhu4, Jie Tian5, Dong Shen2,6, Lixian Yi2,7, Ke Rui2, Jie Ma2, Huaxi Xu1, Shengjun Wang8,9.   

Abstract

Rheumatoid arthritis (RA) is characterized by chronic synovial inflammation and subsequent joint destruction. Previous studies have confirmed that Th17 cells play a critical role in the pathogenesis of RA. MicroRNA (miR)-301a-3p is a regulatory factor for Th17 cells differentiation that contributes to the pathogenesis of autoimmune diseases. The purposes of this study were to identify the alteration of Th17 cells and analyze the correlation between the expression of the miR-301a-3p and the proportion of Th17 cells in RA patients. The results showed that the frequency of Th17 cells and the expression of transcription factors (RORγt and STAT3) significantly increased in the peripheral blood mononuclear cells (PBMCs) from RA patients, and the associated proinflammatory cytokines were also upregulated. We also observed that the expression of protein inhibitor of activated STAT3 (PIAS3), the main cellular inhibitor of STAT3, was attenuated in RA patients and negatively correlated with the percentage of Th17 cells in RA. Interestingly, miR-301a-3p, an inhibitor of PIAS3 expression, was overexpressed in the PBMCs from RA patients and positively correlated with the frequency of Th17 cells in patients with RA. Taken together, these data indicated that miR-301a-3p and Th17 cells were augmented in peripheral blood, which may play an important role in the process of RA.

Entities:  

Keywords:  Th17 cells; microrna-301a; rheumatoid arthritis

Mesh:

Substances:

Year:  2016        PMID: 26782362     DOI: 10.1007/s10753-016-0304-8

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  31 in total

1.  MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination.

Authors:  Marcin P Mycko; Maria Cichalewska; Agnieszka Machlanska; Hanna Cwiklinska; Magdalena Mariasiewicz; Krzysztof W Selmaj
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-18       Impact factor: 11.205

Review 2.  Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.

Authors:  Sima Sh Farid; Gholamreza Azizi; Abbas Mirshafiey
Journal:  Int J Rheum Dis       Date:  2013-07-15       Impact factor: 2.454

3.  Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.

Authors:  Eva V Acosta-Rodriguez; Giorgio Napolitani; Antonio Lanzavecchia; Federica Sallusto
Journal:  Nat Immunol       Date:  2007-08-05       Impact factor: 25.606

4.  MiR-346 regulates CD4⁺CXCR5⁺ T cells in the pathogenesis of Graves' disease.

Authors:  Juan Chen; Jie Tian; Xinyi Tang; Ke Rui; Jie Ma; Chaoming Mao; Yingzhao Liu; Liwei Lu; Huaxi Xu; Shengjun Wang
Journal:  Endocrine       Date:  2015-02-11       Impact factor: 3.633

5.  STAT3 regulates cytokine-mediated generation of inflammatory helper T cells.

Authors:  Xuexian O Yang; Athanasia D Panopoulos; Roza Nurieva; Seon Hee Chang; Demin Wang; Stephanie S Watowich; Chen Dong
Journal:  J Biol Chem       Date:  2007-02-03       Impact factor: 5.157

6.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

7.  A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses.

Authors:  Elisabetta Volpe; Nicolas Servant; Raphaël Zollinger; Sofia I Bogiatzi; Philippe Hupé; Emmanuel Barillot; Vassili Soumelis
Journal:  Nat Immunol       Date:  2008-05-04       Impact factor: 25.606

8.  Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis.

Authors:  Rita Cascão; Rita A Moura; Inês Perpétuo; Helena Canhão; Elsa Vieira-Sousa; Ana F Mourão; Ana M Rodrigues; Joaquim Polido-Pereira; Mário V Queiroz; Henrique S Rosário; Maria M Souto-Carneiro; Luis Graca; João E Fonseca
Journal:  Arthritis Res Ther       Date:  2010-10-20       Impact factor: 5.156

9.  Circulating microRNA expression profiles associated with systemic lupus erythematosus.

Authors:  Anting Liu Carlsen; Aaron J Schetter; Christoffer T Nielsen; Christian Lood; Steen Knudsen; Anne Voss; Curtis C Harris; Thomas Hellmark; Mårten Segelmark; Søren Jacobsen; Anders A Bengtsson; Niels H H Heegaard
Journal:  Arthritis Rheum       Date:  2013-05

Review 10.  IL-17 as a future therapeutic target for rheumatoid arthritis.

Authors:  Wim B van den Berg; Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2009-10       Impact factor: 20.543

View more
  14 in total

Review 1.  MicroRNA-mediated regulation of T helper type 17/regulatory T-cell balance in autoimmune disease.

Authors:  Cuilian Liu; Haoran Yang; Weiyun Shi; Ting Wang; Qingguo Ruan
Journal:  Immunology       Date:  2018-09-10       Impact factor: 7.397

2.  The Impact of Cardiac Lipotoxicity on Cardiac Function and Mirnas Signature in Obese and Non-Obese Rats with Myocardial Infarction.

Authors:  Gema Marín-Royo; Adriana Ortega-Hernández; Ernesto Martínez-Martínez; Raquel Jurado-López; María Luaces; Fabián Islas; Dulcenombre Gómez-Garre; Beatriz Delgado-Valero; Esther Lagunas; Bunty Ramchandani; Mónica García-Bouza; María Luisa Nieto; Victoria Cachofeiro
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

3.  Protein inhibitor of activated STAT3 reduces peripheral arthritis and gut inflammation and regulates the Th17/Treg cell imbalance via STAT3 signaling in a mouse model of spondyloarthritis.

Authors:  Hong-Ki Min; JeongWon Choi; Seon-Yeong Lee; Hyeon-Beom Seo; KyungAh Jung; Hyun Sik Na; Jun-Geol Ryu; Seung-Ki Kwok; Mi-La Cho; Sung-Hwan Park
Journal:  J Transl Med       Date:  2019-01-10       Impact factor: 5.531

Review 4.  Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer's disease.

Authors:  Soheil Madadi; Heidi Schwarzenbach; Massoud Saidijam; Reza Mahjub; Meysam Soleimani
Journal:  Cell Biosci       Date:  2019-11-12       Impact factor: 7.133

5.  Therapeutic Potential of Exosomal circRNA Derived from Synovial Mesenchymal Cells via Targeting circEDIL3/miR-485-3p/PIAS3/STAT3/VEGF Functional Module in Rheumatoid Arthritis.

Authors:  Juan Zhang; Yue Zhang; Yeye Ma; Lili Luo; Maolin Chu; Zhiyi Zhang
Journal:  Int J Nanomedicine       Date:  2021-12-03

6.  MiR-301a-3p Advances IRAK1-Mediated Differentiation of Th17 Cells to Promote the Progression of Systemic Lupus Erythematosus via Targeting PELI1.

Authors:  Shuaihantian Luo; Ruifang Wu; Qianwen Li; Guiying Zhang
Journal:  J Healthc Eng       Date:  2021-12-11       Impact factor: 2.682

Review 7.  miRNAs as Biomarkers and Possible Therapeutic Strategies in Rheumatoid Arthritis.

Authors:  Tomasz Kmiołek; Agnieszka Paradowska-Gorycka
Journal:  Cells       Date:  2022-01-28       Impact factor: 6.600

Review 8.  Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders.

Authors:  Chary Lopez-Pedrera; Nuria Barbarroja; Alejandra Mª Patiño-Trives; Maria Luque-Tévar; Carmen Torres-Granados; Mª Angeles Aguirre-Zamorano; Eduardo Collantes-Estevez; Carlos Pérez-Sánchez
Journal:  Int J Mol Sci       Date:  2020-03-16       Impact factor: 5.923

Review 9.  Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?

Authors:  Carolina Lavoz; Sandra Rayego-Mateos; Macarena Orejudo; Lucas Opazo-Ríos; Vanessa Marchant; Laura Marquez-Exposito; Antonio Tejera-Muñoz; Juan F Navarro-González; Alejandra Droguett; Alberto Ortiz; Jesús Egido; Sergio Mezzano; Raúl R Rodrigues-Diez; Marta Ruiz-Ortega
Journal:  J Clin Med       Date:  2020-01-19       Impact factor: 4.241

10.  Exploring the Extracellular Vesicle MicroRNA Expression Repertoire in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with TNF Inhibitors.

Authors:  Joanna Wielińska; Rachel E Crossland; Piotr Łacina; Jerzy Świerkot; Bartosz Bugaj; Anne M Dickinson; Katarzyna Bogunia-Kubik
Journal:  Dis Markers       Date:  2021-09-30       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.